We have been making improvements to the experience and performance of this page!
Skip to the results
29 Results filtered by...
Filter
Tags > pregnancy Clear All

External Link
These archived cumulative COVID-19 vaccination coverage estimates are for persons who were pregnant anytime from December 20, 2020, to January 20, 2022, and received at least 1 dose of COVID-19 vaccine during pregnancy based on data from the Vaccine Safety Datalink*. As of January 20, 2022, after moving to reporting weekly estimates, the figures on https://covid.cdc.gov/covid-data-tracker/#vaccinations-pregnant-women no longer present cumulative estimates, and these archived data are no longer updated.
For these cumulative data, on December 15, 2021, an error was identified where pregnant people who had received an additional or booster dose of a COVID-19 vaccine were not included in the coverage estimates. After correcting the error, coverage estimates for the week of December 11, 2021, increased overall and by race/ethnicity. The persons that were inadvertently excluded have been counted in the December 11, 2021, estimates. Prior weeks’ estimates have not been updated.
Tags covid-19 vaccine covid tracker pregnancy vsd
Updated
July 26 2023
Views
570

External Link
This table presents the number of pregnant and postpartum Medicaid and CHIP beneficiaries, 2017-2021. It includes (1) the number and percentage of beneficiaries ever pregnant in the year; (2) the number and percentage of live births in the year; (3) the number and percentage of miscarriages, stillbirths, or terminations in the year; and (4) the number and percentage of births with an unknown delivery outcome in the year.
These metrics are based on data in the T-MSIS Analytic Files (TAF). Some states have serious data quality issues, making the data unusable for identifying this population. Data for a state are considered unusable based on DQ Atlas thresholds for the following topics: Total Medicaid and CHIP Enrollment, Claims Volume - IP, Claims Volume - OT, Claims Volume - IP, Diagnosis Code - IP, Diagnosis Code - OT, Procedure Codes - OT Professional. Cells with a value of “DQ” indicate that data were suppressed due to unusable data.
Data from Maryland, Tennessee, and Utah are omitted from the tables due to data quality concerns. Maryland was excluded in 2017 due to unusable diagnosis codes in the IP file and the OT file. Tennessee was excluded due to unusable diagnosis codes in the IP file in 2017 - 2019. Utah was excluded due to unusable procedure codes on OT professional claims in 2017 - 2020. In addition, states with a high data quality concern on one or more measures are noted in the table in the "Data Quality" column. Please refer to the DQ Atlas at http://medicaid.gov/dq-atlas for more information about data quality assessment methods.
Some cells have a value of “DS”. This indicates that data were suppressed for confidentiality reasons because the group included fewer than 11 beneficiaries.
Tags chip maternal health medicaid pregnancy
Updated
January 8 2024
Views
172

External Link
This data set includes monthly counts and rates (per 1,000 beneficiaries) of pregnancy outcomes, including (1) live births and (2) miscarriages, stillbirths, and terminations, for female Medicaid and CHIP beneficiaries ages 15 to 44 (as of the first day of the month), by state.
These metrics are based on data in the T-MSIS Analytic Files (TAF). Some states have serious data quality issues for one or more months, making the data unusable for calculating pregnancy measures. To assess data quality, analysts adapted measures featured in the DQ Atlas. Data for a state and month are considered unusable if at least one of the following topics meets the DQ Atlas threshold for unusable: Total Medicaid and CHIP Enrollment, Procedure Codes - OT Professional, Claims Volume - OT. Please refer to the DQ Atlas at http://medicaid.gov/dq-atlas for more information about data quality assessment methods. Cells with a value of “DQ” indicate that data were suppressed due to unusable data.
Some cells have a value of “DS”. This indicates that data were suppressed for confidentiality reasons because the group included fewer than 11 beneficiaries.
Tags chip dq atlas medicaid pregnancy t-msis analytic files
Updated
January 8 2024
Views
204

External Link
Weekly RSV Vaccination Coverage, Pregnant Persons 18-49 Years Old
• RSV vaccination coverage among pregnant persons is assessed through the Vaccine Safety Datalink*
• Data on RSV vaccinations among pregnant persons was available starting September 22, 2023, and includes doses received starting September 24, 2023.
Tags pregnancy rsv vsd
Updated
April 18 2024
Views
60

External Link
Monthly Nirsevimab Receipt and Intent Among Females Aged 18-49 Years Who Have a Baby <8 Months, Are Currently Pregnant, or Are Trying to Get Pregnant.
• Using data from the National Immunization Survey-Adult COVID Module (NIS-ACM), monthly estimates of receipt and intent for baby’s receipt of nirsevimab reported by females aged 18-49 years with infants under the age of 8 months, females aged 18-49 years who are currently pregnant, and females aged 18-49 years who are currently trying to get pregnant.
• The NIS-ACM is an ongoing random-digit-dial cellular telephone survey of households with adults 18 years and older.
Tags nis-acm pregnancy rsv vaccination
Updated
April 18 2024
Views
50

External Link
This table presents the number of beneficiaries with a delivery, the number of beneficiaries with any SMM condition, and the rate of SMM conditions per 10,000 deliveries, 2017 - 2021.
These metrics are based on data in the T-MSIS Analytic Files (TAF). Some states have serious data quality issues, making the data unusable for identifying this population. Data for a state are considered unusable based on DQ Atlas thresholds for the following topics: Total Medicaid and CHIP Enrollment, Claims Volume - IP, Claims Volume - OT, Claims Volume - IP, Diagnosis Code - IP, Diagnosis Code - OT, Procedure Codes - OT Professional. Cells with a value of “DQ” indicate that data were suppressed due to unusable data.
Data from Maryland, Tennessee, and Utah are omitted from the tables due to data quality concerns. Maryland was excluded in 2017 due to unusable diagnosis codes in the IP file and the OT file. Tennessee was excluded due to unusable diagnosis codes in the IP file in 2017 - 2019. Utah was excluded due to unusable procedure codes on OT professional claims in 2017 - 2020. In addition, states with a high data quality concern on one or more measures are noted in the table in the "Data Quality" column. Please refer to the DQ Atlas at http://medicaid.gov/dq-atlas for more information about data quality assessment methods.
Some cells have a value of “DS”. This indicates that data were suppressed for confidentiality reasons because the group included fewer than 11 beneficiaries.
Tags chip maternal health medicaid pregnancy
Updated
September 11 2024
Views
91

External Link
Weekly COVID-19 Vaccination Coverage, Pregnant Persons 18-49 Years Old
• COVID-19 vaccination coverage among pregnant persons is assessed through the Vaccine
Safety Datalink*
• Data on updated 2023-24 COVID-19 vaccinations among pregnant persons was available starting September 23, 2023, and includes doses received starting September 14, 2023.
Tags adult covid-19 vaccination pregnancy vsd
Updated
August 28 2024
Views
62

External Link

The National Intimate Partner and Sexual Violence Survey (NISVS) is an ongoing, nationally representative survey to assess experiences of intimate partner violence, sexual violence and stalking among adults in the United States. It measures lifetime victimization for these types of violence as well as in the previous 12 months. In 2010, a total of 18,049 interviews from the general population sample were conducted.


Raw data are currently unavailable. State report tables are available in pdf format. Other key statistics are included in the summary and full reports.

Tags adolescent adult child female pregnancy and 15 more
Updated
July 25 2023
Views
751

External Link
Data on infant, neonatal, postneonatal, fetal, and perinatal mortality rates by selected characteristics of the mother. Please refer to the PDF or Excel version of this table in the HUS 2019 Data Finder (https://www.cdc.gov/nchs/hus/contents2019.htm) for critical information about measures, definitions, and changes over time.
SOURCE: NCHS, National Vital Statistics System, public-use Linked Birth/Infant Death Data Set, public-use Fetal Death File, and public-use Birth File. For more information on the National Vital Statistics System, see the corresponding Appendix entry at https://www.cdc.gov/nchs/data/hus/hus19-appendix-508.pdf.
Tags african americans alaskan natives american natives asian continental ancestry group pregnancy and 13 more
Updated
July 25 2023
Views
473

External Link

The primary objective of the National Pregnancy and Health

Survey (NPHS) was to produce national annual estimates of the

percentages and numbers of mothers of live newborns in the United

States who used selected licit and illicit drugs in the 12 months

prior to delivery. A further objective was to describe patterns of

prenatal substance use among demographic subgroups of

women. Information on demographic and socioeconomic characteristics,

obstetric history, and drug treatment of women who delivered infants

at sampled hospitals was obtained through an interviewer-administered

questionnaire, while data on substance use before and during pregnancy

were collected through a questionnaire completed by the respondent and

concealed from the interviewer. Respondents were asked about use of

the following substances: alcohol, amphetamines, analgesics, cocaine,

crack cocaine, barbiturates, hallucinogens, hashish, heroin,

marijuana, methadone, methamphetamine, sedatives, stimulants, tobacco,

and tranquilizers. Additionally, information was collected on the

respondent's pregnancy, prenatal care, delivery, previous pregnancies,

and background. Additional data were obtained from the mothers' and

infants' medical records. Urine specimens collected routinely by the

hospital on obstetric admissions were tested for selected

drugs. Finally, in a subsample of six hospitals, hair specimens were

requested from respondents to evaluate the potential of hair as a

source of toxicological data in future studies.This study has 1 Data Set.

Tags alcohol amphetamines cocaine demographic characteristics pregnancy and 16 more
Updated
July 26 2023
Views
566